Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 57, Issue 2

Issues

Extremely low high-density-lipoprotein cholesterol due to an unusual non-inherited cause: a case report

Arjan J. Kwakernaak / Marco C. Post / Annemarie H. Pijlman / Madeleen BosmaORCID iD: https://orcid.org/0000-0003-0547-0100
Published Online: 2018-08-08 | DOI: https://doi.org/10.1515/cclm-2018-0501

References

  • 1.

    Pirillo A, Catapano AL, Norata GD. HDL in infectious diseases and sepsis. Handb Exp Pharmacol 2015;224:483–508.CrossrefPubMedGoogle Scholar

  • 2.

    Catapano AL, Pirillo A, Bonacina F, Norata GD. HDL in innate and adaptive immunity. Cardiovasc Res 2014;103:372–83.Web of SciencePubMedCrossrefGoogle Scholar

  • 3.

    Koopal C, Visseren FL, Kastelein JJ, Westerink J. Premature atherosclerosis, extremely low HDL-cholesterol and concurrent defects in APOA1 and ABCA1 genes: a family case report. Int J Cardiol 2014;177:e19–21.CrossrefWeb of SciencePubMedGoogle Scholar

  • 4.

    Soran H, Hama S, Yadav R, Durrington PN. HDL functionality. Curr Opin Lipidol 2012;23:353–66.PubMedCrossrefGoogle Scholar

  • 5.

    Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007;117:746–56.Web of SciencePubMedCrossrefGoogle Scholar

  • 6.

    Namiri-Kalantari R, Gao F, Chattopadhyay A, Wheeler AA, Navab KD, Farias-Eisner R, et al. The dual nature of HDL: anti-inflammatory and pro-inflammatory. Biofactors 2015;41:153–9.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 7.

    Odegaard JI, Chawla A. Old HDL learns a new (anti-inflammatory) trick. Nat Immunol 2014;15:138–9.Web of SciencePubMedCrossrefGoogle Scholar

  • 8.

    Denis W. Cholesterol in human blood under pathological conditions. J Biol Chem 1917;29:93–110.Google Scholar

  • 9.

    Montecucco F, Favari E, Norata GD, Ronda N, Nofer JR, Vuilleumier N. Impact of systemic inflammation and autoimmune diseases on ApoA-I and HDL plasma levels and functions. Handb Exp Pharmacol 2015;224:455–82.PubMedCrossrefGoogle Scholar

  • 10.

    Wilhelm AJ, Zabalawi M, Grayson JM, Weant AE, Major AS, Owen J, et al. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol 2009;29:843–9.CrossrefWeb of SciencePubMedGoogle Scholar

  • 11.

    Wilhelm AJ, Zabalawi M, Owen JS, Shah D, Grayson JM, Major AS, et al. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem 2010;285:36158–69.CrossrefWeb of ScienceGoogle Scholar

  • 12.

    Mahdy Ali K, Wonnerth A, Huber K, Wojta J. Cardiovascular disease risk reduction by raising HDL cholesterol – current therapies and future opportunities. Br J Pharmacol 2012;167:1177–94.CrossrefWeb of SciencePubMedGoogle Scholar

  • 13.

    Gonzalez-Pacheco H, Amezcua-Guerra LM, Vazquez-Rangel A, Martinez-Sanchez C, Perez-Mendez O, Verdejo J, et al. Levels of high-density lipoprotein cholesterol are associated with biomarkers of inflammation in patients with acute coronary syndrome. Am J Cardiol 2015;116:1651–7.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 14.

    van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003;31:1359–66.PubMedCrossrefGoogle Scholar

  • 15.

    Guo L, Ai J, Zheng Z, Howatt DA, Daugherty A, Huang B, et al. High density lipoprotein protects against polymicrobe-induced sepsis in mice. J Biol Chem 2013;288:17947–53.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 16.

    Birjmohun RS, van Leuven SI, Levels JH, van ’t Veer C, Kuivenhoven JA, Meijers JC, et al. High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol 2007;27:1153–8.Web of SciencePubMedCrossrefGoogle Scholar

  • 17.

    Norata GD, Pirillo A, Ammirati E, Catapano AL. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 2012;220:11–21.CrossrefWeb of SciencePubMedGoogle Scholar

  • 18.

    Wei XB, Chen XJ, Li YL, Huang JL, Chen XL, Yu DQ, et al. Apolipoprotein A-I: a favorable prognostic marker in infective endocarditis. J Clin Lipidol 2018;12:498–505.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 19.

    Kahveci G, Bayrak F, Mutlu B, Gurel YE, Karaahmet T, Tigen K, et al. Clinical significance of high-density lipoprotein cholesterol in left-sided infective endocarditis. Am J Cardiol 2008;101:1170–3.PubMedCrossrefWeb of ScienceGoogle Scholar

About the article

Corresponding author: Dr. ir. Madeleen Bosma, Department of Clinical Chemistry, St. Antonius Hospital, P.O. Box 2500, 3430 EM Nieuwegein/Utrecht, The Netherlands


Received: 2018-05-10

Accepted: 2018-06-12

Published Online: 2018-08-08

Published in Print: 2018-12-19


Author contributions: AJK, MCP and AP were involved in patient management. MB was the consulted clinical chemist involved with this case. AK and MB wrote the manuscript. MCP and AP reviewed and edited the manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 2, Pages e15–e18, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2018-0501.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in